Cure My Disease

Don't miss your cure!

 Log in / Sign up

Poop power: what makes a perfect stool donor?

NCT ID NCT06478823

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial investigates healthy volunteers who donate stool for fecal microbiota transplantation (FMT), a procedure used to treat certain gut disorders. Researchers aim to identify factors that lead to valid donations, such as donor health and lifestyle, to streamline the donation process. Up to 400 healthy adults aged 18–50 will be followed for up to 12 months to see how many make at least one valid donation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
stool donation
What this could lead to
If successful, this could make fecal microbiota transplantation more efficient and accessible for treating gut disorders.
What could go wrong
This is an observational study focused on donor characteristics, not a treatment trial. It may not directly improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRO-INTESTINAL DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Digestive System Diseases digestive system disorder intestinal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRO-INTESTINAL DISORDER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • LRIPH CRC-Est SAT

    RECRUITING

    Paris, Paris, 75012, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.